Anti-PDLIM1/CLP36 antibody [EPR7186(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal PDLIM1/CLP36 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 4 publications.
View Alternative Names
CLIM1, CLP36, PDLIM1, PDZ and LIM domain protein 1, C-terminal LIM domain protein 1, Elfin, LIM domain protein CLP-36
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-PDLIM1/CLP36 antibody [EPR7186(B)] (AB129015)
ab129015, at 1/100 dilution, staining PDLIM1/CLP36 in permeabilized Saos 2 cells by intracellular flow cytometry or a Rabbit IgG negative control (green).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-PDLIM1/CLP36 antibody [EPR7186(B)] (AB129015)
Immunocytochemistry/ Immunofluorescence analysis of 293T (human embryonic kidney epithelial cell) cells labeling PDLIM1/CLP36 with purified ab129015 at 1/100 dilution (10 μg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL) was used as the secondary antibody only control.
- WB
Unknown
Western blot - Anti-PDLIM1/CLP36 antibody [EPR7186(B)] (AB129015)
All lanes:
Western blot - Anti-PDLIM1/CLP36 antibody [EPR7186(B)] (ab129015) at 1/1000 dilution
Lane 1:
Human heart cell lysate at 10 µg
Lane 2:
L6 cell lysate at 10 µg
Lane 3:
293T cell lysate at 10 µg
Lane 4:
Caco 2 cell lysate at 10 µg
Lane 5:
Saos 2 cell lysate at 10 µg
Lane 6:
C2C12 cell lysate at 10 µg
Lane 7:
Rat lung cell lysate at 10 µg
Lane 8:
Mouse lung cell lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-Rabbit IgG at 1/2000 dilution
Predicted band size: 36 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-PDLIM1/CLP36 antibody [EPR7186(B)] (AB129015)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-PDLIM1/CLP36 antibody [EPR7186(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDLIM1 connects to actin filaments helping in maintaining cytoskeletal dynamics and cell structure. This protein is part of the larger complex involved in organizing actin filaments. PDLIM1 through interactions with cytoskeletal components regulates muscle contraction and cell motility. It stabilizes actin filaments through its PDZ domain and modulates signal transduction pathways linked to cellular adhesion and movement.
Pathways
Studies have identified PDLIM1's involvement in the regulation of signaling pathways such as the MAPK and Wnt pathways. Through these processes PDLIM1 interacts with proteins like kinases and phosphatases which play a role in signal transduction and cellular communication. By modulating these pathways PDLIM1 influences cell growth and differentiation processes critical in tissue development and maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 13:5820 PubMed37037887
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:5456016 PubMed36164345
2022
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 12:5051-5068 PubMed35836803
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 5:18327 PubMed26679095
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com